Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T‐cell therapy for chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T‐cell therapy for chronic lymphocytic leukemia

Published:2019-03-23 Issue:S1 Volume:94 Page:S10-S17
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Bair Steven M.¹^ORCID,Porter David L.¹

Affiliation:

1. Cell Therapy and Transplant Program, Division of Hematology‐Oncology, Perelman School of Medicine and Abramson Cancer CenterUniversity of Pennsylvania Philadelphia Pennsylvania

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25457

Reference86 articles.

1. SEER.Cancer Stat Facts: Luekemia—Chronic Lymphocytic Leukemia (CLL).https://seer.cancer.gov/statfacts/html/clyl.html. Accessed February 12 2019.

2. Long-term Follow-up of Treatment with Ibrutinib and Rituximab in Patients with High-Risk Chronic Lymphocytic Leukemia

3. Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens

4. Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL

5. Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling and Simulation of CAR T cell Therapy in Chronic Lymphocytic Leukemia Patients;2022-12-01

2. CD38 as a multifaceted immunotherapeutic target in CLL;Leukemia & Lymphoma;2022-08-17

3. Therapeutic applications of engineered chimeric antigen receptors-T cell for cancer therapy;Beni-Suef University Journal of Basic and Applied Sciences;2022-04-11

4. Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia;Leukemia & Lymphoma;2022-03-08

5. Chronic Lymphocytic Leukaemia;The EBMT/EHA CAR-T Cell Handbook;2022